Market Place
Sourcing Support
Fujifilm Diosynth Completes Facility Expansion in CA
21 Nov 2024 //
CONTRACTPHARMA
FUJIFILM Diosynth Starts Phase 1 Of Global CDMO Expansion
05 Nov 2024 //
PRESS RELEASE
FUJIFILM Diosynth Signs Supply Deal With TG Therapeutics
04 Nov 2024 //
PRESS RELEASE
Fujifilm Diosynth Opens Billingham, UK Microbial Manufacturing Facility
20 Aug 2024 //
CONTRACT PHARMA
Fujifilm Diosynth`s restructuring may leave 240 out of work
17 Apr 2024 //
FIERCE PHARMA
Fujifilm plots another $1.2B expansion, hiring spree at NC site
12 Apr 2024 //
FIERCE PHARMA
FUJIFILM Diosynth Expands Manufacturing Agreement with Argenx for Efgartigimod
25 Mar 2024 //
PRESS RELEASE
FUJIFILM Diosynth Biotechnologies Appoints Richard McAvoy as CFO
11 Mar 2024 //
PRESS RELEASE
FUJIFILM Diosynth Announces Renewable Energy Denmark Manufacturing Site
29 Feb 2024 //
PRESS RELEASE
First in POLITICO: “Fujifilm’s pharmaceutical arm plants a flag in Washington.”
16 Jan 2024 //
PRESS RELEASE
FUJIFILM Diosynth Biotechnologies and SHL Medical Enter strategic partnership
08 Jan 2024 //
PRESS RELEASE
Fujifilm secures J&J as first tenant at $2bn Holly Springs plant
09 Nov 2023 //
BIOPROCESS INTERNATIONAL
Fujifilm Diosynth forms new business structure
28 Aug 2023 //
FIERCE PHARMA
Fujifilm Diosynth’s CEO Lars Petersen talks priorities and plans for the CDMO
06 Jul 2023 //
ENDPTS
Fujifilm Diosynth names Lars Petersen to replace Martin Meeson as CEO
30 Jun 2023 //
ENDPTS
Fujifilm to Enhance Commercial Presence in Asia for Biologics and Advanced Therapies Contract Services
07 Jun 2023 //
PRESS RELEASE
Fujifilm Diosynth Biotechnologies’ Biologics Production Facility Expansion, Hillerod, Denmark
19 May 2023 //
PHARMACEUTICAL-TECHNOLOGY
FUJIFILM Diosynth Biotechnologies Acquires Additional 41 Acres of Land in RTP
19 Apr 2023 //
PRESS RELEASE
Fujifilm Diosynth CEO Martin Meeson says company is in `growth mode`
01 Mar 2023 //
ENDPTS
FUJIFILM Diosynth Biotechnologies: There’s a New Cell Therapy Employer
05 Dec 2022 //
BIOSPACE
Fujifilm Diosynth Biotechnologies Expands Partnership with NC State
15 Nov 2022 //
CONTRACTPHARMA
FUJIFILM enters into an Agreement with Argenx to Manufacture Efgartigimod
27 Oct 2022 //
PRESS RELEASE
Fujifilm Diosynth Biotechnologies Celebrates the Start of Its Expansion Project
26 Oct 2022 //
CONTRACTPHARMA
FUJIFILM Held Celebration for Expansion of Single-Use Manufacturing Campus
25 Oct 2022 //
PRESS RELEASE
FUJIFILM & RoosterBio to Collaborate to enable GMP Manufacturing of Cell
24 Oct 2022 //
PRESS RELEASE
Novavax to pay Fujifilm for cancelled manufacturing contract
08 Oct 2022 //
FIERCEPHARMA
Fujifilm continues CDMO expansion, breaking ground on $435M UK site
23 Sep 2022 //
ENDPTS
FUJIFILM Breaks Ground on Microbial Manufacturing Facility Expansion in UK
22 Sep 2022 //
PRESS RELEASE
Fujifilm Diosynth breaks ground on a $1.6B expansion project in Denmark
15 Sep 2022 //
ENDPTS
FUJIFILM breaks ground on a USD 1.6 billion expansion in Hillerød, Denmark
12 Sep 2022 //
PRESS RELEASE
Fujifilm`s $1.6B CDMO investment will create 450 new jobs
30 Jun 2022 //
FIERCEPHARMA
Chimeron Bio Selects Mfg. Partner FUJIFILM Diosynth Biotechnologies
12 Apr 2022 //
CONTRACTPHARMA
Fujifilm completes acquisition of Atara`s cell therapy manufacturing site
08 Apr 2022 //
ENDPTS
FUJIFILM Diosynth Biotechnologies Gifts $200,000 to Wake Tech Foundation to Establish Early College Suite
17 Mar 2022 //
PRESS RELEASE
Atara Biotherapeutics Enters Strategic Manufacturing Partnership with Fujifilm
26 Jan 2022 //
BUSINESSWIRE
FUJIFILM Diosynth Biotechnologies Invests £400M in UK Bio-Mfg. Site
02 Dec 2021 //
CONTRACTPHARMA
Fujifilm draws back curtain on U.K. CDMO expansion
02 Dec 2021 //
FIERCEPHARMA
Fujifilm Diosynth Biotechnologies, Istari Oncology Enter Manufacturing Agreement
27 Oct 2021 //
CONTRACTPHARMA
For Fujifilm, the rush is on to build CDMO capacity
26 Oct 2021 //
FIERCEPHARMA
Fujifilm breaks ground on massive NC site
21 Oct 2021 //
ENDPTS
LEXEO Therapeutics and FUJIFILM Diosynth Biotechnologies Announce Collaboration
13 Oct 2021 //
GLOBENEWSWIRE
FUJIFILM Diosynth Biotechnologies, NeuExcell Enter Gene Therapy Mfg. Pact
13 Sep 2021 //
CONTRACT PHARMA
FDA issues form 483 to Fujifilm Diosynth Biotechnologies USA
26 Aug 2021 //
FDA
Novavax, Fujifilm plow ahead on Covid-19 vaccine production despite OWS setback
12 Aug 2021 //
ENDPTS
Fujifilm is pumping $850M into its U.S., U.K. production
01 Jul 2021 //
FIERCEPHARMA
Fujifilm Chooses North Carolina for New $2-Billion Cell Culture Facility
22 Mar 2021 //
PHARMTECH
Pfizer, WuXi Bio, Fujifilm and more—Fierce Pharma Asia
19 Mar 2021 //
FIERCEPHARMA
Fujifilm invests $2 B to build largest cell culture biopharma CDMO in US
19 Mar 2021 //
BIOSPECTRUMASIA
Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership
17 Mar 2021 //
CONTRACTPHARMA
Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark
05 Mar 2021 //
CONTRACTPHARMA
Fujifilm`s Avigan shows no significant benefit on COVID-19 mortality: study
18 Feb 2021 //
REUTERS
FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site
16 Feb 2021 //
CONTRACTPHARMA
Fujifilm doubles down on Boston area with another new CDMO site
19 Jan 2021 //
FIERCE PHARMA
Fujifilm to Establish New Manufacturing and Innovation Center in Massachusetts
18 Jan 2021 //
PHARMTECH
Fujifilm doubles down on Boston area with another new CDMO site
16 Jan 2021 //
FIERCE PHARMA
Fujifilm injects $76M funding on Manufacturing and Innovation Center
15 Jan 2021 //
BIOSPECTRUMASIA
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
14 Jan 2021 //
CONTRACTPHARMA
Fujifilm injects $76M funding on Manufacturing and Innovation Center
14 Jan 2021 //
BIOSPECTRUMASIA
Fujifilm doubles down on Boston foothold, renting some major legroom
14 Jan 2021 //
ENDPTS
